Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominance

A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases

(2018) Emily J Erbelding et al.   JOURNAL OF INFECTIOUS DISEASES

Chasing Seasonal Influenza — The Need for a Universal Influenza Vaccine

(2018) Catharine I. Paules et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antibody Immunodominance: The Key to Understanding Influenza Virus Antigenic Drift

(2018) Meghan O. Altman et al.   VIRAL IMMUNOLOGY

Update: Influenza Activity — United States, October 1, 2017–February 3, 2018

(2018) Alicia P. Budd et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Interim Estimates of 2017–18 Seasonal Influenza Vaccine Effectiveness — United States, February 2018

(2018) Brendan Flannery et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Influenza A Viruses Expressing Intra- or Intergroup Chimeric Hemagglutinins

(2016) Chi-Jene Chen et al.   JOURNAL OF VIROLOGY

Epitope mapping of the 2009 pandemic and the A/Brisbane/59/2007 seasonal (H1N1) influenza virus haemagglutinins using mAbs and escape mutants

(2014) M. Retamal et al.   JOURNAL OF GENERAL VIROLOGY

Epitope Mapping of the Hemagglutinin Molecule of A/(H1N1)pdm09 Influenza Virus by Using Monoclonal Antibody Escape Mutants

(2014) Y. Matsuzaki et al.   JOURNAL OF VIROLOGY

Substitutions Near the Receptor Binding Site Determine Major Antigenic Change During Influenza Virus Evolution

(2013) B. F. Koel et al.   SCIENCE

Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model

(2012) Laurent Coudeville et al.   BMC Medical Research Methodology

Cross-neutralization of influenza A viruses mediated by a single antibody loop

(2012) Damian C. Ekiert et al.   NATURE

Comparative Analysis of Hemagglutination Inhibition Titers Generated Using Temporally Matched Serum and Plasma Samples

(2012) Gabriel N. Defang et al.   PLoS One

Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells

(2012) G.-M. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Influenza Human Monoclonal Antibody 1F1 Interacts with Three Major Antigenic Sites and Residues Mediating Human Receptor Specificity in H1N1 Viruses

(2012) Tshidi Tsibane et al.   PLoS Pathogens

Influenza Hemagglutination-Inhibition Antibody Titer as a Correlate of Vaccine-Induced Protection

(2011) Suzanne E. Ohmit et al.   JOURNAL OF INFECTIOUS DISEASES

Structural Characterization of the Hemagglutinin Receptor Specificity from the 2009 H1N1 Influenza Pandemic

(2011) R. Xu et al.   JOURNAL OF VIROLOGY

A Broadly Neutralizing Human Monoclonal Antibody That Recognizes a Conserved, Novel Epitope on the Globular Head of the Influenza H1N1 Virus Hemagglutinin

(2011) J. C. Krause et al.   JOURNAL OF VIROLOGY

Identification of a Highly Conserved H1 Subtype-Specific Epitope with Diagnostic Potential in the Hemagglutinin Protein of Influenza A Virus

(2011) Rongmao Zhao et al.   PLoS One

Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin

(2011) J. R. R. Whittle et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA